Polycystic Ovary Syndrome: An Apparently Simple yet Challenging Diagnosis

Author Information
Article Notes and Dates
To Cite : Ramezani Tehrani F. Polycystic Ovary Syndrome: An Apparently Simple yet Challenging Diagnosis, Int J Endocrinol Metab. 2015 ;13(3):e28557. doi: 10.5812/ijem.28557v2.
Copyright: Copyright © 2015, International Journal of Endocrinology and Metabolism. .
  • 1. Hosseinpanah F, Barzin M, Keihani S, Ramezani Tehrani F, Azizi F. Metabolic aspects of different phenotypes of polycystic ovary syndrome: Iranian PCOS Prevalence Study. Clin Endocrinol (Oxf). 2014; 81(1): 93-9[DOI][PubMed]
  • 2. Tehrani FR, Rashidi H, Khomami MB, Tohidi M, Azizi F. The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran. Reprod Biol Endocrinol. 2014; 12: 89[DOI][PubMed]
  • 3. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004; 81(1): 19-25[DOI][PubMed]
  • 4. Rashidi H, Ramezani Tehrani F, Bahri Khomami M, Tohidi M, Azizi F. To what extent does the use of the Rotterdam criteria affect the prevalence of polycystic ovary syndrome? A community-based study from the Southwest of Iran. Eur J Obstet Gynecol Reprod Biol. 2014; 174: 100-5[DOI][PubMed]
  • 5. Broekmans FJ, Knauff EA, Valkenburg O, Laven JS, Eijkemans MJ, Fauser BC. PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG. 2006; 113(10): 1210-7[PubMed]
  • 6. Conway G, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Franks S, Gambineri A, et al. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. Eur J Endocrinol. 2014; 171(4)-29[DOI][PubMed]
  • 7. Ramezani Tehrani F, Minooee S, Azizi F. Validation of a simplified method to assess hirsutism in the Iranian population. Eur J Obstet Gynecol Reprod Biol. 2014; 174: 91-5[DOI][PubMed]
  • 8. Tan JK, Bhate K. A global perspective on the epidemiology of acne. Br J Dermatol. 2015; [DOI][PubMed]
  • 9. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009; 91(2): 456-88[DOI][PubMed]
  • 10. Van Uytfanghe K, Stockl D, Kaufman JM, Fiers T, De Leenheer A, Thienpont LM. Validation of 5 routine assays for serum free testosterone with a candidate reference measurement procedure based on ultrafiltration and isotope dilution-gas chromatography-mass spectrometry. Clin Biochem. 2005; 38(3): 253-61[DOI][PubMed]
  • 11. Hashemi S, Ramezani Tehrani F, Noroozzadeh M, Azizi F. Normal cut-off values for hyperandrogenaemia in Iranian women of reproductive age. Eur J Obstet Gynecol Reprod Biol. 2014; 172: 51-5[DOI][PubMed]
  • 12. Malcolm C. Does anovulation exist in eumenorrheic women? Obstetrics & Gynecology. 2003; 102(2): 317-8[DOI]
  • 13. Lujan ME, Jarrett BY, Brooks ED, Reines JK, Peppin AK, Muhn N, et al. Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume. Hum Reprod. 2013; 28(5): 1361-8[DOI][PubMed]
  • 14. Amer SA, Li TC, Bygrave C, Sprigg A, Saravelos H, Cooke ID. An evaluation of the inter-observer and intra-observer variability of the ultrasound diagnosis of polycystic ovaries. Hum Reprod. 2002; 17(6): 1616-22[PubMed]
  • 15. Petrikova J, Figurova J, Dravecka I, Lazurova I. [Is polycystic ovary syndrome associated with autoimmune thyroiditis?]. Vnitr Lek. 2012; 58(11): 830-3[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Cited By:

International Journal of Endocrinology and Metabolism accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check